NasdaqCM - Nasdaq Real Time Price USD

Unicycive Therapeutics, Inc. (UNCY)

Compare
0.6840 -0.0260 (-3.66%)
At close: December 20 at 4:00:01 PM EST
0.6999 +0.02 (+2.32%)
After hours: December 20 at 7:55:34 PM EST

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 72.46M 38.49M 18.84M 47.96M 30.16M 29.89M
Enterprise Value 40.92M 43.53M 16.82M 39.07M 16.72M 38.21M
Trailing P/E -- -- -- -- -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales 23.75 -- -- 50.17 25.19 8.02
Price/Book 2.60 -- -- 14.15 8.90 --
Enterprise Value/Revenue 16.63 -- -- 57.88 24.77 23.50
Enterprise Value/EBITDA -1.03 -- -- -- -2.17 -9.02
9/30/2023 - 7/12/2021

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 6/30/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -53.37%
Return on Equity (ttm) -121.76%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) 0.00
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA -28.84M
Net Income Avi to Common (ttm) -24.41M
Diluted EPS (ttm) -0.4600
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 41.78M
Total Cash Per Share (mrq) 0.44
Total Debt (mrq) 634k
Total Debt/Equity (mrq) 2.02%
Current Ratio (mrq) 3.37
Book Value Per Share (mrq) -0.11

Cash Flow Statement

Operating Cash Flow (ttm) -21.64M
Levered Free Cash Flow (ttm) -16.69M

Trading Information

Stock Price History

Beta (5Y Monthly) 2.29
52 Week Range 3 14.00%
S&P 500 52-Week Change 3 24.21%
52 Week High 3 1.8180
52 Week Low 3 0.2020
50-Day Moving Average 3 0.5589
200-Day Moving Average 3 0.7005

Share Statistics

Avg Vol (3 month) 3 1.54M
Avg Vol (10 day) 3 1.37M
Shares Outstanding 5 103.8M
Implied Shares Outstanding 6 103.8M
Float 8 61.45M
% Held by Insiders 1 6.73%
% Held by Institutions 1 38.24%
Shares Short (10/31/2024) 4 1.05M
Short Ratio (10/31/2024) 4 0.74
Short % of Float (10/31/2024) 4 1.21%
Short % of Shares Outstanding (10/31/2024) 4 1.12%
Shares Short (prior month 9/30/2024) 4 993.82k

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers